HSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Food and Drug Administration (FDA) regarding FDA’s recently published list of essential medicines, medical countermeasures (MCM), and their critical inputs. HSCA and our member companies are committed to ensuring continued patient access to critical medical products.
Click...
Learn MoreHSCA Statement on President Biden’s Executive Order on the Healthcare Supply Chain
HSCA Statement on President Biden’s Executive Order on the Healthcare Supply Chain
Washington, DC (January 22, 2021) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement regarding President Biden’s Executive Order on a sustainable public health supply chain:
“HSCA and its member group purchasing organizations (GPOs) applaud...
Learn MoreHSCA Submits Comments to FDA on Using Unique Device Identifiers in Medical Device Safety Communications to Support Accuracy, Quality, and Patient Safety
Washington, DC (January 19, 2021) – The Healthcare Supply Chain Association (HSCA) Committee for Healthcare eStandards (CHeS) today submitted comments to the U.S. Food and Drug Administration (FDA) encouraging the agency to use unique device identifiers (UDI) to improve FDA communications regarding the safety of medical devices.
Patients across the country rely on medical devices in their...
Learn MoreHSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. International Trade Commission (USITC) regarding supply chain challenges related to COVID-19 and critical medical products. HSCA appreciates the Commission’s leadership and efforts to-date to help identify COVID-related materials and goods and increase access to these...
Learn MoreHSCA Letter to the House Committee on Energy and Commerce
Dear Chairman Pallone and Ranking Member Walden:
On behalf of the Healthcare Supply Chain Association (HSCA), we applaud your continued leadership on,
and commitment to, bipartisan legislation that advances the public health and supports a safe, reliable,
and affordable supply of critical medical products.
HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs),...
Learn MoreHSCA Comments to the Senate HELP Committee on Planning for the Next Pandemic
Dear Chairman Alexander and Ranking Member Murray:
On behalf of the Healthcare Supply Chain Association (HSCA), we applaud your leadership to promote U.S. public health preparedness and response. Through commitment to advancing recommendations to help prepare for the next pandemic, we can best work to provide critical support in emergencies facing this nation. The unprecedented nature of...
Learn MoreComments of the Healthcare Supply Chain Association on USTR Request for Comments on Additional Tariff Exclusions for COVID-19 Response
Dear Ambassador Lighthizer:
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on additional modifications of actions regarding Chinese exports under Section 301. HSCA is dedicated to supporting patient care and ensuring healthcare providers have access to critical medical supplies needed to...
Learn More